439 related articles for article (PubMed ID: 23172272)
1. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.
Weiss DJ; Casaburi R; Flannery R; LeRoux-Williams M; Tashkin DP
Chest; 2013 Jun; 143(6):1590-1598. PubMed ID: 23172272
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic umbilical cord-derived mesenchymal stem cell transplantation for treating chronic obstructive pulmonary disease: a pilot clinical study.
Le Thi Bich P; Nguyen Thi H; Dang Ngo Chau H; Phan Van T; Do Q; Dong Khac H; Le Van D; Nguyen Huy L; Mai Cong K; Ta Ba T; Do Minh T; Vu Bich N; Truong Chau N; Van Pham P
Stem Cell Res Ther; 2020 Feb; 11(1):60. PubMed ID: 32054512
[TBL] [Abstract][Full Text] [Related]
3. Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
Weiss DJ; Segal K; Casaburi R; Hayes J; Tashkin D
Respir Res; 2021 May; 22(1):142. PubMed ID: 33964910
[TBL] [Abstract][Full Text] [Related]
4. Combined Bone Marrow-Derived Mesenchymal Stromal Cell Therapy and One-Way Endobronchial Valve Placement in Patients with Pulmonary Emphysema: A Phase I Clinical Trial.
de Oliveira HG; Cruz FF; Antunes MA; de Macedo Neto AV; Oliveira GA; Svartman FM; Borgonovo T; Rebelatto CL; Weiss DJ; Brofman PR; Morales MM; Lapa E Silva JR; Rocco PR
Stem Cells Transl Med; 2017 Mar; 6(3):962-969. PubMed ID: 28186686
[TBL] [Abstract][Full Text] [Related]
5. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
Matthay MA; Calfee CS; Zhuo H; Thompson BT; Wilson JG; Levitt JE; Rogers AJ; Gotts JE; Wiener-Kronish JP; Bajwa EK; Donahoe MP; McVerry BJ; Ortiz LA; Exline M; Christman JW; Abbott J; Delucchi KL; Caballero L; McMillan M; McKenna DH; Liu KD
Lancet Respir Med; 2019 Feb; 7(2):154-162. PubMed ID: 30455077
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study.
Zheng G; Huang L; Tong H; Shu Q; Hu Y; Ge M; Deng K; Zhang L; Zou B; Cheng B; Xu J
Respir Res; 2014 Apr; 15(1):39. PubMed ID: 24708472
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic human umbilical cord-derived mesenchymal stem/stromal cells for chronic obstructive pulmonary disease (COPD): study protocol for a matched case-control, phase I/II trial.
Hoang DM; Nguyen KT; Nguyen AH; Nguyen BN; Nguyen LT
BMJ Open; 2021 May; 11(5):e045788. PubMed ID: 33986057
[TBL] [Abstract][Full Text] [Related]
9. CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
Lazaar AL; Miller BE; Donald AC; Keeley T; Ambery C; Russell J; Watz H; Tal-Singer R;
Respir Res; 2020 Jun; 21(1):149. PubMed ID: 32532258
[TBL] [Abstract][Full Text] [Related]
10. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
11. β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol.
Bhatt SP; Connett JE; Voelker H; Lindberg SM; Westfall E; Wells JM; Lazarus SC; Criner GJ; Dransfield MT
BMJ Open; 2016 Jun; 6(6):e012292. PubMed ID: 27267111
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
13. A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).
Savitz SI; Yavagal D; Rappard G; Likosky W; Rutledge N; Graffagnino C; Alderazi Y; Elder JA; Chen PR; Budzik RF; Tarrel R; Huang DY; Hinson JM
Circulation; 2019 Jan; 139(2):192-205. PubMed ID: 30586746
[TBL] [Abstract][Full Text] [Related]
14. Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Tashkin DP; Rennard S; Hays JT; Ma W; Lawrence D; Lee TC
Chest; 2011 Mar; 139(3):591-599. PubMed ID: 20864613
[TBL] [Abstract][Full Text] [Related]
15. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of an oral MMP-9 and -12 inhibitor, AZD1236, in patients with moderate-to-severe COPD: a randomised controlled 6-week trial.
Magnussen H; Watz H; Kirsten A; Wang M; Wray H; Samuelsson V; Mo J; Kay R
Pulm Pharmacol Ther; 2011 Oct; 24(5):563-70. PubMed ID: 21624491
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional profiling of circulating mononuclear cells from patients with chronic obstructive pulmonary disease receiving mesenchymal stromal cell infusions.
Armitage JD; Tan DBA; Sturm M; Moodley YP
Stem Cells Transl Med; 2021 Nov; 10(11):1470-1481. PubMed ID: 34405962
[TBL] [Abstract][Full Text] [Related]
18. Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.
Zheng JP; Wen FQ; Bai CX; Wan HY; Kang J; Chen P; Yao WZ; Ma LJ; Li X; Raiteri L; Sardina M; Gao Y; Wang BS; Zhong NS;
Lancet Respir Med; 2014 Mar; 2(3):187-94. PubMed ID: 24621680
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.
Zheng JP; Yang L; Wu YM; Chen P; Wen ZG; Huang WJ; Shi Y; Wang CZ; Huang SG; Sun TY; Wang GF; Xiong SD; Zhong NS
Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625
[TBL] [Abstract][Full Text] [Related]
20. Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
Wise RA; Chapman KR; Scirica BM; Bhatt DL; Daoud SZ; Zetterstrand S; Reisner C; Gil EG
JAMA; 2019 May; 321(17):1693-1701. PubMed ID: 31063575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
